| Bioactivity | Iclaprim is a new selective bacterial Dihydrofolate inhibitor, which can inhibit the growth of S. aureus (MRSA) with an MIC90 of 0.06 μg/mL. | ||||||||||||
| Invitro | Iclaprim inhibits the growth of S. aureus (MRSA) with an MIC90 of 0.06 μg/mL[2]. | ||||||||||||
| Name | Iclaprim | ||||||||||||
| CAS | 192314-93-5 | ||||||||||||
| Formula | C19H22N4O3 | ||||||||||||
| Molar Mass | 354.40 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
Iclaprim
CAS: 192314-93-5 F: C19H22N4O3 W: 354.40
Iclaprim is a new selective bacterial Dihydrofolate inhibitor, which can inhibit the growth of S. aureus (MRSA) with an
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.